Blueprint Medicines Total Current Liabilities 2014-2024 | BPMC

Blueprint Medicines total current liabilities for the quarter ending September 30, 2024 were $0.258B, a 30.54% increase year-over-year.

  • Blueprint Medicines total current liabilities for 2023 were $0.215B, a 17.29% increase from 2022.
  • Blueprint Medicines total current liabilities for 2022 were $0.183B, a 22.35% increase from 2021.
  • Blueprint Medicines total current liabilities for 2021 were $0.15B, a 14.5% increase from 2020.

Blueprint Medicines Total Current Liabilities 2014-2024 | BPMC

  • Blueprint Medicines total current liabilities for 2023 were $0.215B, a 17.29% increase from 2022.
  • Blueprint Medicines total current liabilities for 2022 were $0.183B, a 22.35% increase from 2021.
  • Blueprint Medicines total current liabilities for 2021 were $0.15B, a 14.5% increase from 2020.